Sean Salmon
CIK 1792380 · EVP & President Cardiovascular · last filed 2025-12-11
Sean Salmon is an EVP & President Cardiovascular who has filed 23 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing, for ADGM, was dated Dec 11, 2025. Across all open-market trades the lifetime net is −$7.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$5.62M
2
23
-$7.76M
Holdings By Company
Recent Filings
23 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-11 | ADGM | Grant (A) | — | $0 | EDGAR |
| 2025-06-06 | MDT | Notice (144) | −18,378 | -$1.60M | EDGAR |
| 2024-12-17 | MDT | Tax (F) | −645 | -$53.2K | EDGAR |
| 2024-08-06 | MDT | Mixed | +2,026 | -$280.1K | EDGAR |
| 2024-07-31 | MDT | Grant (A) | +14,375 | $0 | EDGAR |
| 2024-02-23 | MDT | Mixed | — | -$492.9K | EDGAR |
| 2024-02-21 | MDT | Notice (144) | −30,695 | -$2.61M | EDGAR |
| 2023-12-12 | MDT | Tax (F) | −435 | -$34.5K | EDGAR |
| 2023-08-07 | MDT | Mixed | +1,235 | -$369.1K | EDGAR |
| 2023-08-02 | MDT | Grant (A) | +9,686 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.